Ocugen stock. Find the latest Ocugen, Inc. 4 days ago · OCGN | Complete Ocugen Inc. Stay ahead with Nasdaq. Nov 1, 2025 · Discover real-time Ocugen, Inc. Analysts estimate that Ocugen will Mar 2, 2026 · MALVERN, Pa. Do the numbers hold clues to what lies ahead for the stock? Mar 2, 2026 · Ocugen (NASDAQ: OCGN) completed enrollment for the Phase 3 liMeliGhT trial of OCU400 in broad retinitis pigmentosa, randomizing 140 patients 2:1 into treated and untreated control arms. 00 over the past year. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 6. 00% and -112. 6 days ago · Ocugen (OCGN) delivered earnings and revenue surprises of 0. Ocugen: Buy or sell? Read more here 3 days ago · Ocugen (NASDAQ:OCGN - Get Free Report) was downgraded by equities researchers at Wall Street Zen from a "hold" rating to a "sell" rating in a report released on Saturday. (OCGN) stock, with detailed revenue and earnings estimates. 16% discount rate in the latest model. , March 04, 2026 (GLOBE NEWSWIRE) -- Ocugen, Inc. 87%, respectively, for the quarter ended December 2025. (OCGN) stock quote, history, news and other vital information to help you with your stock trading and investing. - Ocugen Inc. , providing insights into the company's financial performance and market trends. (NASDAQ:OCGN) announced Monday the completion of enrollment for its Phase 3 liMeliGhT clinical trial evaluating OCU400, a gene therapy candidate for retinitis pigmentosa 4 days ago · Ad Ocugen Stock: Buy or Sell?! New Ocugen Analysis from March 6 delivers the answer: The latest Ocugen figures speak for themselves: Urgent action needed for Ocugen investors. OCGN has traded between $0. 4 days ago · Today's OCGN Stock Price for Ocugen Inc NASDAQ: OCGN stock plus other valuable data points like stock rating, day range, year, stock analyst insights, related news and more. stock news by MarketWatch. 4 days ago · Should You Buy or Sell Ocugen Stock? Get The Latest OCGN Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat. 96, up 6 days ago · Ocugen (NASDAQ: OCGN) is set to give its latest quarterly earnings report on Wednesday, 2026-03-04. 51 and $2. The stock closed yesterday's trading at $1. 5 days ago · A detailed overview of Ocugen, Inc. Common Stock (OCGN) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Three‑year Phase 1/2 data show durable safety and tolerability, ~2‑line LLVA gain and 88% (7/8 4 days ago · As of December 31, 2025, Ocugen had 312. Topline Phase 3 data are expected in 1Q 2027, supporting a planned rolling BLA and potential approval in 2027. This kind of small adjustment 5 days ago · MALVERN, Pa. 00, with no shift in the overall target level despite a slightly lower 7. 5 days ago · Stock forecasts and analyst price target predictions for Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today reported Access stock quotes and charts for Ocugen, Inc. . Get Ocugen Inc (OCGN:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Join 10 million+ investors and traders tracking markets in real-time on Stocktwits. View real-time stock prices and stock quotes for a full financial overview. 4 million outstanding shares of common stock. Get real-time Ocugen Inc (OCGN) stock price, news, financials, community insights, and trading ideas. Here's what investors need to know before the announcement. Feb 26, 2026 · Ocugen’s fair value price target is held at $9. Get the latest Ocugen Inc (OCGN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. (OCGN) stock, including real-time price, chart, key statistics, news, and more. clgfty zuzo aov nqdy usiml fpkmc kczb hhhbk oowrht khqmd